A biodegradable suction patch for sustainable transbuccal peptide delivery.
Krupke. Hanna H; Zoratto. Nicole N; Rabut. Lucie L; Gao. Daniel D; Paunović. Nevena N; Klein Cerrejon. David D; Dehapiot. Benoit B; Leroux. Jean-Christophe JC
Key Findings
- Biodegradable copolyester patches can be massâproduced and safely dissolve after removal, reducing waste.
- In dogs, a 10âminute buccal application of the patch delivered semaglutide with much higher bioavailability than an oral tablet and achieved ~26% of the exposure of a subcutaneous injection for bremelanotide.
- Ex vivo tests on pig cheek tissue showed the patch, combined with a chemical permeation enhancer, significantly increased the passage of otherwise poorly permeable molecules.
Practical Outcomes
- For DIY peptide users, this patch offers a needleâfree way to administer PTâ141 and similar peptides, potentially improving convenience and adherence. A short (â10âŻmin) application is enough to achieve meaningful blood levels, and the biodegradable material means you wonât be adding plastic waste. While still experimental, the data suggest you could replace subcutaneous injections with a buccal patch for certain peptides, pending further human safety testing.
Summary
Scientists made a new, ecoâfriendly suction patch you stick on the inside of your cheek that can deliver peptide drugs without a needle. It works for semaglutide (a weightâloss/diabetes peptide) and bremelanotide (the active ingredient in PTâ141), giving decent blood levels after just a 10âminute application, and the patch breaks down after use.
Abstract
Despite considerable advances in the systemic delivery of peptides, their susceptibility to gastrointestinal degradation and high molecular weight, which restricts permeability across biological barriers, remain obstacles to oral administration. As a result, most peptide therapies rely on injections to achieve therapeutic effects. Recent studies on a bioinspired suction patch demonstrated positive effects in vivo with three peptides - desmopressin, semaglutide, and teriparatide - yet materials used for patch fabrication were non-degradable. In this work, a more sustainable patch alternative is introduced by replacing previously used materials with biodegradable polymers, aiming for degradation of the patch after removal to reduce environmental impact. A scalable mold casting process was employed to thermally crosslink synthesized and functionalized copolyesters, yielding the desired devices. Mechanical testing across various materials and shapes identified the best-performing polymer, while its degradation was confirmed in both aqueous medium and simulated waste. An ex vivo model using porcine buccal tissue validated the functionality of biodegradable patches, showing enhanced permeation of a poorly permeable dye when combined with a chemical permeation enhancer. In beagle dogs, the bioavailability of semaglutide (4.11 kDa) was substantially improved compared to the commercially available tablet, with an application time of only 10 min. Additionally, the patch achieved a relative bioavailability of 26% for bremelanotide (1.03 kDa) compared to subcutaneous administration. This work underscores the potential of replacing silicone devices with biodegradable alternatives, providing a more sustainable approach for peptide delivery via the buccal suction patch.
Study Information
pubmed
2025
2025-06-11T00:00:00.000Z
10.1016/j.jconrel.2025.113947
1
69